"

华体会网页登录入口_注册拥有全球最顶尖的原生APP,每天为您提供千场精彩体育赛事,华体会网页登录入口_注册更有真人、彩票、电子老虎机、真人电子竞技游戏等多种娱乐方式选择,华体会网页登录入口_注册让您尽享娱乐、赛事投注等,且无后顾之忧!

<p id="xptln"><b id="xptln"><progress id="xptln"></progress></b></p>

<address id="xptln"></address>

<form id="xptln"><th id="xptln"><progress id="xptln"></progress></th></form>

    <form id="xptln"></form>

    <address id="xptln"><address id="xptln"><listing id="xptln"></listing></address></address>
    <address id="xptln"><nobr id="xptln"><meter id="xptln"></meter></nobr></address>

    <address id="xptln"></address>"
    当前位置: 首页 - 新闻中心 - 2021两会声音

    【CGTN】于清明:国药3-17岁人群新冠疫苗待审批上市

    发布时间:2021-03-10 来源: 阅读次数:19

    转自CGTN微博:https://4m.cn/0Zq3e

           全国人大代表、国药集团国药控股董事长于清明在接受CGTN记者@尤杨Diana-CGTN 采访时,分享了国药集团研制适合3-17岁人群疫苗的最新情况。他说,目前该疫苗临床试验III期证实安全有效,已进入待审批上市阶段。于清明还表示,国药集团今年将保障疫苗年产量达10亿剂,全力保障国内和国际市场。"Results from clinical trials show that the vaccines for people aged 3-17 are safe and effective," Yu Qingming, NPC deputy and chairman of Sinopharm Holding, told CGTN. Currently, 60 million people have received Sinopharm's vaccines worldwide, and in 2021, the company will expand its production to 1 billion doses, Yu added.

     

    华体会网页登录入口_注册 <p id="xptln"><b id="xptln"><progress id="xptln"></progress></b></p>

    <address id="xptln"></address>

    <form id="xptln"><th id="xptln"><progress id="xptln"></progress></th></form>

      <form id="xptln"></form>

      <address id="xptln"><address id="xptln"><listing id="xptln"></listing></address></address>
      <address id="xptln"><nobr id="xptln"><meter id="xptln"></meter></nobr></address>

      <address id="xptln"></address>